Unitaid

Unitaid invests in groundbreaking technologies to help patients succeed in TB treatment

Geneva, 23 July 2019 – The KNCV Tuberculosis Foundation and Unitaid signed a US$ 13.9 million grant agreement on Tuesday to increase the use of smart pillboxes and mobile technology, aiming to help patients adhere to their medicines and raise the world’s plateauing cure rates for TB.

Read More →

Unitaid’s investment in TB hits record levels with new grant for diagnostic technologies

Geneva – The Foundation for Innovative New Diagnostics (FIND) and Unitaid signed a US$ 14.5 million grant Thursday (July 4) to deploy a powerful new technology in the diagnosis of drug-resistant tuberculosis.

Read More →

UNICEF and Unitaid join forces to improve the health of children, adolescents and mothers

Geneva, 29 May 2019 –Unitaid and UNICEF will collaborate to save the lives of more children, adolescents and mothers, an agreement formalized by a memorandum of understanding signed today.

Read More →

Unitaid and Japan move to align their efforts against TB

Tokyo, 2 April 2019 — Unitaid Executive Director Lelio Marmora and Parliamentary Vice-Minister for Foreign Affairs of Japan Kenji Yamada met today to discuss a new alignment between Japan’s global health priorities and Unitaid’s work in fighting tuberculosis.

Read More →

CROI 2019: New study is a breakthrough for preventing TB in people living with HIV

Geneva – A Unitaid-funded study has found that 3HP, a new, shorter preventive therapy for tuberculosis, is safe for people who also take the HIV drug dolutegravir. The results mark a critical milestone for countries and funding partners seeking to expand preventive TB therapy.

Read More →

Unitaid seeks innovative, long-lasting technologies to help tackle diseases

Geneva – Unitaid is pleased to announce a call for proposals for projects speeding development of long-acting versions of medicines that could potentially revolutionize treatment and prevention of diseases including HIV, tuberculosis and malaria in low- and middle-income countries.

Read More →

Unitaid extends support to WHO prequalification programme

Geneva, 30 January 2019 – Unitaid is investing a further $22.1 million in the World Health Organization´s (WHO) prequalification programme for medicines and diagnostics.

Read More →

MPP and Unitaid publish intellectual property report on long-acting technologies

The Medicines Patent Pool (MPP) and Unitaid have jointly published a study into the patent landscape for long-acting technologies with the potential to have a major impact on preventing or treating HIV, hepatitis C, tuberculosis, and malaria in low- and middle-income countries.

Read More →

Unitaid extends key research grant as part of a strong counterattack on TB

New York, 25 September 2018 – Unitaid is intensifying its commitment to fighting tuberculosis with a US$ 21 million investment in extending endTB, a global research project that is improving treatment regimens for patients with multidrug-resistant tuberculosis (MDR-TB).

Read More →

Price cut on medicine will help preserve the health of more people living with HIV

Geneva, 08 June 2018 — Unitaid and Indian drug manufacturer Cipla Ltd. struck a landmark agreement today that will lower the price of the first combination therapy (containing co-trimoxazole, isoniazid and vitamin B6) that prevents opportunistic infections in people living with HIV.

Read More →

Page 1 of 3 · Total posts: 10

1 2 Last→